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INTRODUCTION
Brucellosis is a zoonosis that has a worldwide distribution,
and it remains as a major source of disease for both humans
and domestic animals particularly in the Mediterranean re-
gion, Western Asia and in parts of Africa and Latin America
(1). According to a review of the literature, bovine brucellosis
was eradicated in Japan in 1992 and in North Korea in 1959
(1). Although human brucellosis has been rarely reported in
the East Asian countries until now, bovine brucellosis has been
sporadically reported since 1947 and it has increased to above
100 cases per year since 1984 in the Republic of Korea (ROK)
(2, 3). After 1990, the cases of bovine brucellosis have increa-
sed to above 500 cases every year (3-6). Furthermore, in 2003,
1,088 cases of bovine brucellosis were reported in ROK (7).
Because of increasing trend for bovine brucellosis in ROK,
there is now a greater possibility for humans to become infect-
ed with brucellosis than at any time during the past 2 decades.
Although several studies have been performed to detect hu-
man brucellosis, they did not find any such cases (4-6). The
first suspected case of human brucellosis in ROK was that of
a livestock worker in 2002 (3). Recently, there was a report of
an outbreak of human brucellosis among livestock workers
and veterinarians in rural area around Jeongeup City, Jeolla-
buk-Do, Korea, from February 2003 to August 2003. Altho-
ugh brucellosis has mainly been a problem of veterinarians
for past five decades, this local sporadic outbreak demonstrat-
ed that Brucella abortus biotype 1 in humans has emerged as
an important public health problem in ROK.
In this report, we describe the clinical characteristics and
the serologic data in the II cases of human brucellosis and also
discuss and the efficacy and side effects of a rifampin and doxy-
cyline regimen for the treatment of human brucellosis. 
MATERIALS AND METHODS 
Patients
An epidemiological investigation was conducted to iden-
tify the vehicle and the source of the brucellosis infection. We
also tried to describe the circumstances of the outbreak and
establish the control measures to be taken by the Division of
Zoonoses, Center for Immunology and Pathology, National
Institute of Health, Korea.
Jeoungeup City is an administrative district region consist-
ing of Sintaein Eup, fourteen Myens including Ipyong, Deok-
cheon, and Gobu, and 15 Dongs. These regions are very close
to northwest Jeongeup City. In 2003, the cow stock in Sin-
taein, Ipyong, Deokcheon and Gobu accounted for 16.8% of
the total cow population of the Jeongeup City region.
A suspicious case of human brucellosis was defined as a per-
son who was residing in regions of Sintaein, Ipyong, Deok-
cheon or Gobu, and who presented with vague clinical symp-
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Eleven cases of human brucellosis occurred among livestock workers and a veteri-
narian who lived and worked in a rural area around Jeongeup City, Jeollabuk-Do,
Korea from February 2003 to August 2003. Eight of the patients had taken care of
Korean native cattle that were infected with bovine brucellosis and had already been
slaughtered. Two of the patients had taken care of dairy cattle, and one case was
a veterinarian who acquired the disease through an accidental contact with infected
cattle while assisting in calf delivery. Eleven cases were identified by serologic work
ups and four cases were identified via positive blood cultures. This study shows that
the Republic of Korea is no longer free of human brucellosis, Brucella abortus bio-
type 1. We reviewed the patients’ characteristics and serologic data during the one-
year follow up period, and we also discuss on the efficacy and side effects of the
rifampin and doxycyline regimen used for the treatment of human brucellosis.
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toms of brucellosis such as fever of unknown origin, unexplai-
ned weight loss, fatigue etc. from February 2003 to August
2003. A serologic screening with the standard tube aggluti-
nation test (STA) was done in fifty patients who had a history
of a contact with cows diagnosed with bovine brucellosis and
who also had the unexplained vague symptoms described abo-
ve. The eleven probable cases among the fifty suspicious cases
included patients who had a positive STA titer of ≥1:160,
a positive PCR result, or positive scrological results by ELISA.
A confirmed case was defined as a serologically diagnosed case
that revealed a positive blood culture (8).
Serological and microbiological culture methods 
The serologic tests were performed regularly starting at the
patients’ first visit to the district health service center; the tests
were repeated six weeks after the start of treatment and at 8,
12, 16, 20, 24 (at 4 weeks, interval for 6 months) and 48 weeks
later. 
The district health service center referred the blood samples
to the Division of Zoonoses, Center for Immunology and
Pathology, National Institute of Health, Seoul, Korea. The
blood cultures were processed with the automatic blood cul-
ture system (BACTEC 9050, BD Co, Sparks, Maryland,
U.S.A.), and they were incubated for 5 to 7 days. If there were
any positive signs, a “blind” subculture was done with Tryptic
Soy agar (containing 5% sheep blood, Difco, Detroit, MI,
U.S.A.) for 2 to 3 days in 5% CO2 at 37℃. The human iso-
lates of the Brucella strain were identified using the standard
method (9).
STA and ELISA for the IgM and IgG antibodies to B. abor-
tus were performed for each serum sample. All the samples
from the same patient were processed simultaneously by the
progressive double-dilution method. Different antigens were
also used for detection in each of the assays. A suspension of
B. abortus antigen (Difco Laboratories) was prepared as the an-
tigen for the tube agglutination test. A B. abortus diagnostic
kit (Pan Bio, Brisbane, Australia) was used for the ELISA IgG
and IgM tests. To find any cross-reactivity with other Gram-
negative bacteria, we performed STA procedures with Yersinia
enterocolitica (ATCC 9610), and Francisella tularensis (Germaine,
San Antonio, Texas, U.S.A.). However, no cross-reactivity was
noted. Although there is no single titer of Brucella antibodies
that is 100% diagnostic, most cases of active infection have
titers of 1:160 or greater for IgM, along with positive IgG
antibodies. The cut-off values were 11 for the IgM and IgG. 
The template DNA was extracted by using a blood DNA
purification kit (Gentra, Minneapolis, Minnesota, U.S.A.) from
the blood of the patients. PCR was performed in a 50  L vol-
ume containing the following; 10  L template DNA, 0.025
U Taq DNA polymerase (Promega, Madison, WI, U.S.A.), 3
L MgCl2 (25 mM), 5  L 10×PCR reaction buffer (1.5 mM),
1  L PCR Nucleotide Mix (10 mM each), and 10 pM of
each primer. The primers were genus-specific primer pairs
designed to amplify the gene encoding a 31-kDa, 36-kDa
and 16S rRNA fragment of the genus Brucella (9, 10) (Table
1). The cycling condition included an initial denaturation
step at 94℃ for 10 min, and the template was cycled 35
times (1 min of denaturation at 95℃, 1 min of annealing
at 60℃and 5 min of extension at 72℃) by a thermal cycler
(Perkin-Elmer PCR system 9700). The positive control con-
tained B. abortus ATCC 7705 DNA (biotype 1) as the tem-
plate, and the negative control consisted of sterile water instead
of the DNA template. The PCR products were resolved by
electrophoresis on 2% agarose gel with ethidium bromide
(0.5 mg/mL). 
RESULTS
A total of eleven cases were identified at the local outbreak;
the cultures were positive in four cases, and seven cases were
serologically diagnosed (Table 2). Fig. 1 shows the distribution
of the patients who presented with human brucellosis in the
Jeougeup city area, Jeollabuk-Do, Korea. Eight patients were
male and 3 patients were female, and their ages ranged from
38 to 51 yr old (mean, 45 yr). Ten patients were livestock wor-
kers and one patient was a veterinarian who acquired the dis-
ease through an accidental contact with infected cows while
assisting in calf delivery. In our study, all the cases were inter-
viewed to discover the mode of transmission. However, they
denied buying or consuming unpasteurized milk, but they
Fig. 1. The number of case of human brucellosis diagnosed in Jeo-
ngeup City, Jeollabuk-do, Korea in 2003.
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Target
Oligonucleotide Amplified  Target 
sequences product (bp) species
BCSP 31 F: 5′ -TGGCTCGGTTGCCAATATCAA-3′ 223 Brucella
R: 5′ -CGCGCTTGCCTTTCAGGTCTG-3 spp.
OMP2 F: 5′ -GCGCTAAGGCTGCCGACGCAA-3′ 193 Brucella
R: 5′ -ACCAGCCATTGCGGTCGGTA-3′ spp.
16S rRNA F: 5′ -TCGAGCGCCCGCAAGGGG-3′ 905 Brucella
R: 5′ -AACCATAGTGTCTCCACTAA-3' spp.
Table 1. The sequences of primers for Brucella used in this studySporadic Outbreak of Human Brucellosis in Korea 943
did consume raw meat, including raw muscle and liver. Case
3, 8 and 9 had a history of eating uncooked fresh muscle and
liver. Although we could not get information about how many
cows were infected or concerning their level of disease because
the cattle had already been slaughtered, the confirmed Bru-
cella biotype 1 bacteria strongly suggested that respiratory
transmission or direct contact transmission was responsible
for the human infections rather than ingestion of the cattle
meat or milk. The patients were probably infected by their
occupational and incidental contact with infected cattle.
The most frequent symptom was fatigue (100%), and other
common complaints are listed in Table 3. The ophthalmologic
examinations revealed only senile cataract changes without
any definitive pathognomonic findings. 
Table 4 shows the one year follow-up serologic data for one
year. The median STA antibody titer for the eleven patients
at the time of their admission was 1:160 (range, 1:40-1:640).
The mean IgM ELISA titer was 57.5 (range, 16-173), and the
mean IgG ELISA titer was 35 (range, 11-76). We used 3 dif-
ferent kinds of primer sets to perform PCR, and all of them
Case No.
(age (yr)/sex)
Occupation Initial symptoms at diagnosis
STA titer Culture result
1 (45/M) Livestock farming Fatigue, decreased visual acuity  1:320 + B. abortus
2 (38/F) Livestock farming Fever, headache, arthralgia, fatigue, depression, eyeball pain 1:80 + B. abortus
3 (46/M) Livestock farming Fever, fatigue 1:160 + -
4 (42/M) Livestock farming* Fatigue, arthralgia, depression, anorexia 1:160 + -
5 (46/M) Livestock farming* Fever, fatigue, headache, arthralgia, depression, anorexia,  1:640 + B. abortus
decreased visual acuity
6 (48/M) Livestock farming Fatigue, arthralgia, malaise, decreased visual acuity 1:160 + -
7 (44/F) Livestock farming Fever, fatigue, arthralgia, eyeball pain 1:80 + -
8 (45/M) Livestock farming Fatigue, depression, weight loss 1:320 + -
9 (42/F) Livestock farming Fatigue, weight loss, chills, cold sweats 1:40  + -
10 (51/M) Livestock farming Headache, fatigue, dizziness 1:160 + -
11 (43/M) Veterinarian Fever, fatigue, headache, anorexia, malaise,  1:320 + B. abortus
depression, eyeball pain
Table 2. Diagnostic features of the patients with active brucellosis
*Diary cattle; +, positive; -, negative; STA, standard tube agglutination test; PCR, polymerase chain reaction.
PCR
Laboratory results
Symptoms Frequency No. (%)
Fatigue 11  (100)
Arthralgia 5  (45)
Depression 5  (45)
Fever 4  (36)
Headache 4  (36)
Decreased visual acuity  3 (27)
Eyeball pain  3 (27)
Anorexia 3  (27)
Weight loss  2 (18)
Malaise 2 (18)
Chills 1 (9)
Dizziness 1 (9)
Cold sweat 1 (9)
Table 3. The clinical findings of 11 patients with brucellosis at the
time of diagnosis 
A
500 bp
233 bp
M 1 2 3 4 5 6 7 8 9 10 11 12 13
500 bp
196 bp
1,000 bp
200 bp
500 bp
M123456789 1 0 1 1 1 2 1 3
M 1 2 3 4 5 6 7 8 9 10 11 12 13
B
C
Fig. 2. Detection of the PCR products of Brucella genes; (A) De-
tection of the Brucella 31 kDa genes PCR products from the 11
patients with brucellosis. lane M; molecular size marker (100-bp
DNA, ladder); lane 1, DNA of B. abortus ATCC 7705 for the posi-
tive control; lane 2 to 12 for the clinical patients; lane 13, distilled
water for the negative control. (B) Detection of the Brucella 36 kDa
genes PCR products from the 11 patients with brucellosis. Lane
M, molecular size marker (100-bp DNA, ladder); lane 1, DNA of B.
abortus ATCC 7705 for the positive control; lane 2, distilled water
for the negative control; lane 3 to 13 for the patients. (C) Detection
of the Brucella 16 S rRNA genes PCR products from the 11 patients
with brucellosis. Lane M, molecular size marker (100-bp DNA, lad-
der); lane 1, DNA of B. abortus ATCC 7705 for the positive control;
lane 2, distilled water for the negative control; lane 3 to 13 for the
patients.showed positive results (Fig. 2). There were 4 positive blood
cultures (36%) at the time of admission. The initial STA titers
of cases 2, 7 and 9 were below the diagnostic value, but their
follow-up titers increased four fold after several weeks and the
results of their PCR tests were all positive. Especially, case 2
had a positive blood culture result. The IgM antibody test re-
sults obtained from the sera at the time of admission were all
above the cutoff levels in all patients, but the IgG levels re-
mained within the normal range in 4 cases (case 3, 4, 7 and
9) (Table 4). Following treatment, the IgM antibody levels
decreased steadily; however, the IgG levels increased at first,
but they steadily decreased thereafter. 
The patients’ treatment was started based on the positive
serologic findings in the suspicious cases because the disease
symptoms were nonspecific. The treatment regimen consisted
of oral doxycycline 100 mg twice a day plus oral rifampin 900
mg/day in a single morning dose, and this regimen was given
from 8 weeks to a maximum of 10 weeks. Among the 11 pa-
tients, one patient had a relapse 5 months after the comple-
tion of the therapy. In this case, the clinical symptoms of se-
vere fatigue, anorexia and weight loss recurred; the blood cul-
ture was positive and the serologic titers for the IgM and IgG
by ELISA were sharply increased. In addition, the titer of the
STA was increased over four fold. This relapsed patient was
re-treated with the same antibiotic regimen for additional 6
more weeks, and then his symptoms and serologic titers im-
proved. We could not find any definitive reason for the relapse.
However, we thought that poor compliance with taking his
medication rather than drug resistance might have been the
primary problem, or reinfection was also a possibility. The
treatment regimen was relatively well tolerated, but gastroin-
testinal disturbance was the major complaint from the medi-
cation. One patient showed melena and hematemesis after
completion of the medication schedule. She continuously com-
plained of gastrointestinal problems and pain while taking
the medication, but she completed the drug course. One week
after the conpletion of the medication schedule, she was diag-
nosed with hemorrhagic esophagitis by flexible gastrofibers-
copy. 
There had been no previous cases of human brucellosis in
these areas. The first series of cases presented with symptoms
on February 2003 and the last case presented on August 2003.
As a consequence, the outbreak duration was deemed to be
about 7 months long.
DISCUSSION
Because brucellosis has a wide spectrum of nonspecific clini-
cal manifestations, this disease may clinically mimic another
febrile illnesses such as typhoid fever and tuberculosis. In addi-
tion, healthcare providers may not consider brucellosis in their
first differential diagnosis. Therefore, there is a strong possi-
bility that the disease may be considerably underdiagnosed.
The possibility of human beings falling ill with brucellosis
has been a reality for a long time in the ROK because bovine
brucellosis has been continuously reported on for many deca-
des. After 1990, the number of cases of bovine brucellosis has
increased to above 400 every year (3-6). Chung et al. reported
that the major B. abortus was biotype 1 in Korean dairy cattle
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Case No. Serology Initial 20 wk 48 wk
1 STA 1:320 1:320 1:40 1:40 - 1:20 1:80 1:40
IgM/IgG 16/40 26/38 7/38 5/35 - 4/27 28/78 9/55
2 STA 1:80 1:320 1:160 - 1:160 - 1:80 1:40
IgM/IgG 69/63 72/56 70/81 - 50/55 - 32/44 -
3 STA 1:160 - 1:80 1:80 - - 1:80 1:160
IgM/IgG 41/11 - 48/10 40/35 - - 46/26 30/22
4 STA 1:160 1:160 1:160 - 1:160 1:160 1:160 1:40
IgM/IgG 48/01 184/14 72/38 - 73/44 42/55 96/97 8/65
5 STA 1:640 - 1:320 - 1:160 - - 1:40
IgM/IgG 71/76 - 75/73 - 25/55 - - -
6 STA 1:160 - 1:80 - 1:40 - 1:40 1:20
IgM/IgG 36/51 - 15/57 - 12/40 - 8/29 4/15
7 STA 1:80 1:80 1:320 - 1:160 - 1:80 1:20
IgM/IgG 40/02 60/07 80/39 - 80/39 - 49/29 28/18
8 STA 1:320 - 1:320 1:160 1:160 1:160 1:160 1:40
IgM/IgG 173/53 - 157/69 60/48 51/43 36/63 25/54 13/29
9 STA 1:40 1:160 - - 1:80 1:80 1:40 1:20
IgM/IgG 44/02 70/11 - - 65/42 39/36 25/22 -
10 STA 1:160 1:320 1:320 - 1:80 - 1:80 1:40
IgM/IgG 40/50 31/54 16/83 - 9/73 - 5/55 -
11 STA 1:320 1:320 1:80 1:40 1:80 - 1:40 <1:20
IgM/IgG 55/34 58/43 32/38 27/37 18/50 - 14/38 -
Table 4. Antibody titers of B. abortus in patients during the approximately 1 yr follow-up period
STA, standard tube agglutination test (>1:160); IgM, immunoglobulin M (>11 unit); IgG, immunoglobulin G (>11 unit).
24 wk 8 wk 2 wk 16 wk 12 wk(11). In this study, the species of Brucella identified was also
biotype 1. Therefore, this microbiological result strongly sug-
gests that B. abortus biotype 1 might be a major pathogenic
species in ROK. Infected cattle shed this organism into the
environment via urine, vaginal secretions, ejaculates, aborted
fetuses or feces. Baek et al. insisted that an indigenous Korean
dog was infected via contacts with infected cattle on the same
farm where the dog was living (12). 
In 2003, there were more than 1,088 cases of bovine brucel-
losis; about 60% of the bovine brucellosis cases in 2003 occu-
rred in the Korean native cattle and the other cases were in
the dairy cattle (6). Korean native cattle are raised to produce
meat, not for milk. By contrast, human brucellosis in the Me-
diterranean regions is acquired from the dairy cattle, goats,
camels and sheep, and these animals can produce contaminat-
ed milk and cheese. So, there is a big difference in the cause
of human brucellosis between ROK and the Mediterranean
area. It was thought that brucellosis in ROK might be trans-
mitted through abraded skin that incurred during the course
of handling infected animals or their carcasses rather than th-
rough the ingestion of unpasteurized dairy products. This
epidemiological difference suggests that anti-epidemic mea-
sure for brucellosis in ROK should be focused on the control
of the Korean native cattle as well as the dairy cattle.
The symptoms in Korean patients were somewhat different
from twose in patients from other countries. Fever, chills and
sweating were the common symptoms, and these were also
the symptoms in more than 70% of the cases from other co-
untries. Arthralgia and cough were also common in the cases
from other countries (13). Of note, fatigue was the most com-
mon symptom, occurring in all patients. 
The culture techniques are time-consuming and they lack
sensitivity for patients having chronic infections; furthermore,
handling these organism in the laboratory is hazardous (14,
15). PCR is a useful modality for the rapid and direct detec-
tion of Brucella DNA in the blood specimens obtained from
persons with brucellosis, and it can provide results to the clini-
cian in less than 24 hr. Moreover, it eliminates the hazards of
handling this organism in the laboratory (16-18). In our study,
PCR was very sensitive. It displayed 100% positive results.
Although blood culture has been held as the gold standard
for the laboratory diagnosis of brucellosis until now, the sensi-
tivity of this technique is very low, ranging from 15% to 70%
(19). Therefore, PCR should also be performed in hospitals,
especially in the endemic countries. 
In our study, the IgM antibody levels determined by ELISA
on the sera obtained at admission were all above the cutoff
levels in all patients, but the IgG levels remained within the
normal range in 4 cases. Irmak et al. (20) reported that altho-
ugh the majority of the patients may present with specific
IgM antibodies as well as with specific IgG antibodie, other
cases may have either specific IgM or specific IgG antibodies.
So in clinical practice, the two assays should be performed as
complementary tests. 
During the follow-up period, case 1 again had positive blood
cultures; this patient experienced a relapse of the disease about
5 months after the end of treatment. In this case, the IgM/IgG
antibodies levels were markedly and sharply elevated. Altho-
ugh the IgM/IgG antibody levels were markedly elevated in
case 3, the patient had no symptoms and the blood cultures
were negative. Several reports have demonstrated that patients
in relapse often show an elevation of the IgG level by ELISA
(9, 21). By contrast, as was reported by Gazapo et al. (10), the
IgM level by ELISA did not elevate. Yet Irmak et al. (20) have
shown that the IgM/IgG antibodies levels were elevated in
relapsed cases, in line with our observation but the IgM titers
were not markedly increased compared with the IgG titers.
The treatment regimen in this study consisted of oral ad-
ministration of doxycycline 100 mg twice a day plus oral ri-
fampin 900 mg/day in a single morning dose for 8 weeks to
a maximum of 10 weeks. There was only a single case of re-
lapse (9.1%). Solera et al. (22) have strongly suggested that
the doxycycline/rifampin regimen is less effective than the
doxycycline/streptomycin regimen in patients with acute bru-
cellosis. The relapse rate in the doxycycline/rifampin group
was 16%, white it was only 5.3% in the doxycycline/strepto-
mycin group. Montejo et al. (23) have reported that the relap-
se rate in the doxycycline/rifampin group was 10.8%. There
was only one relapse case in our study; however, we could not
differentiate between relapse and reinfection with certainty.
The treatment duration in our study was longer than in other
studies because some patients wanted to have longer medica-
tion; the treatment duration in other stu- dies was around 6
weeks (42-45 days) with the doxycycline/ rifampin regimen
(21-23).
In conclusion, this outbreak shows that the ROK is no lon-
ger free of human brucellosis. Those livestock workers who
are suffering with chronic fatigue, arthralgia, depression, fever
and headache without any apparent reasons should visit a phy-
sician for a medical evaluation. The physicians who are living
and working in the regions with endemic bovine brucellosis
have to be aware of the clinical manifestations of human bru-
cellosis and the necessary workup to establish the diagnosis
when indicated. 
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